1. Ex‐vivo analysis of human Natural Killer T cells demonstrates heterogeneity between tissues and within established CD4+ and CD4− subsets. (11th March 2013) Authors: Chan, A. C.; Leeansyah, E.; Cochrane, A.; d' Udekem d' Acoz, Y.; Mittag, D.; Harrison, L. C.; Godfrey, D. I.; Berzins, S. P. Journal: Clinical and experimental immunology Issue: Volume 172:Number 1(2013:Apr.) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy. (January 2014) Authors: Chan, A. C.; Neeson, P.; Leeansyah, E.; Tainton, K.; Quach, H.; Prince, H. M.; Harrison, S. J.; Godfrey, D. I.; Ritchie, D.; Berzins, S. P. Journal: Clinical and experimental immunology Issue: Volume 175:Number 1(2014:Jan.) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗